184 related articles for article (PubMed ID: 25694265)
1. Racial disparities in laryngeal cancer treatment and outcome: A population-based analysis of 24,069 patients.
Shin JY; Truong MT
Laryngoscope; 2015 Jul; 125(7):1667-74. PubMed ID: 25694265
[TBL] [Abstract][Full Text] [Related]
2. Racial disparities in the use of voice preservation therapy for locally advanced laryngeal cancer.
Hou WH; Daly ME; Lee NY; Farwell DG; Luu Q; Chen AM
Arch Otolaryngol Head Neck Surg; 2012 Jul; 138(7):644-9. PubMed ID: 22801888
[TBL] [Abstract][Full Text] [Related]
3. Survival outcomes in advanced laryngeal cancer.
Megwalu UC; Sikora AG
JAMA Otolaryngol Head Neck Surg; 2014 Sep; 140(9):855-60. PubMed ID: 25144163
[TBL] [Abstract][Full Text] [Related]
4. Improvements in survival and disparities for advanced-stage laryngeal cancer.
LeBlanc BJ; Shi R; Mehta V; Mills G; Ampil F; Nathan CA
JAMA Otolaryngol Head Neck Surg; 2015 Feb; 141(2):169-73. PubMed ID: 25429594
[TBL] [Abstract][Full Text] [Related]
5. Temporal trends in the treatment of early- and advanced-stage laryngeal cancer in the United States, 1985-2007.
Chen AY; Fedewa S; Zhu J
Arch Otolaryngol Head Neck Surg; 2011 Oct; 137(10):1017-24. PubMed ID: 22006780
[TBL] [Abstract][Full Text] [Related]
6. The impact of comorbidity on treatment (chemoradiation and laryngectomy) of advanced, nondistant metastatic laryngeal cancer: a review of 16 849 cases from the national cancer database (2003-2008).
Zhu J; Fedewa S; Chen AY
Arch Otolaryngol Head Neck Surg; 2012 Dec; 138(12):1120-8. PubMed ID: 23247231
[TBL] [Abstract][Full Text] [Related]
7. Laryngeal Papillary Squamous Cell Carcinoma: A Population-Based Analysis of Incidence and Survival.
Dutta R; Husain Q; Kam D; Dubal PM; Baredes S; Eloy JA
Otolaryngol Head Neck Surg; 2015 Jul; 153(1):54-9. PubMed ID: 25917664
[TBL] [Abstract][Full Text] [Related]
8. Oncologic benefit of tonsillectomy in stage I and II tonsil cancer: a surveillance epidemiology and end results database review.
Holliday MA; Tavaluc R; Zhuang T; Wang H; Davidson B
JAMA Otolaryngol Head Neck Surg; 2013 Apr; 139(4):362-6. PubMed ID: 23599071
[TBL] [Abstract][Full Text] [Related]
9. Geographic trends in management of early-stage laryngeal cancer.
Mourad M; Dezube A; Moshier E; Shin E
Laryngoscope; 2016 Apr; 126(4):880-4. PubMed ID: 26526215
[TBL] [Abstract][Full Text] [Related]
10. Impact of radiotherapy on laryngeal cancer survival: a population-based study of 13,808 US patients.
Zhang H; Travis LB; Chen R; Hyrien O; Milano MT; Newlands SD; Chen Y
Cancer; 2012 Mar; 118(5):1276-87. PubMed ID: 21773970
[TBL] [Abstract][Full Text] [Related]
11. Racial Differences in the Overall Survival of Hairy Cell Leukemia in the United States: A Population-Based Analysis of the Surveillance, Epidemiology, and End Results Database.
Giri S; Shrestha R; Pathak R; Bhatt VR
Clin Lymphoma Myeloma Leuk; 2015 Aug; 15(8):484-8. PubMed ID: 25882766
[TBL] [Abstract][Full Text] [Related]
12. Primary total laryngectomy versus organ preservation for T3/T4a laryngeal cancer: a population-based analysis of survival.
Dziegielewski PT; O'Connell DA; Klein M; Fung C; Singh P; Alex Mlynarek M; Fung D; Harris JR; Seikaly H
J Otolaryngol Head Neck Surg; 2012 Apr; 41 Suppl 1():S56-64. PubMed ID: 22569051
[TBL] [Abstract][Full Text] [Related]
13. The effect of treatment on survival in patients with advanced laryngeal carcinoma.
Gourin CG; Conger BT; Sheils WC; Bilodeau PA; Coleman TA; Porubsky ES
Laryngoscope; 2009 Jul; 119(7):1312-7. PubMed ID: 19444887
[TBL] [Abstract][Full Text] [Related]
14. Significance of laryngeal edema after partial laryngectomy and radiotherapy in supraglottic cancer.
Oksüz DC; Uzel O; Yildirim A; Yetmen O; Sahinler I; Turkan S
J Otolaryngol Head Neck Surg; 2008 Oct; 37(5):681-8. PubMed ID: 19128676
[TBL] [Abstract][Full Text] [Related]
15. Management of stage IV glottic carcinoma: therapeutic outcomes.
Spector GJ; Sessions DG; Lenox J; Newland D; Simpson J; Haughey BH
Laryngoscope; 2004 Aug; 114(8):1438-46. PubMed ID: 15280724
[TBL] [Abstract][Full Text] [Related]
16. Tumor volumetry as a prognostic factor in the management of T4a laryngeal cancer.
Hsin LJ; Fang TJ; Tsang NM; Chin SC; Yen TC; Li HY; Liao CT; Chen IH
Laryngoscope; 2014 May; 124(5):1134-40. PubMed ID: 24127228
[TBL] [Abstract][Full Text] [Related]
17. Race-specific features and outcomes of nodular lymphocyte-predominant Hodgkin lymphoma: Analysis of the National Cancer Data Base.
Olszewski AJ; Shrestha R; Cook NM
Cancer; 2015 Oct; 121(19):3472-80. PubMed ID: 26149294
[TBL] [Abstract][Full Text] [Related]
18. Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma.
Mathur AK; Osborne NH; Lynch RJ; Ghaferi AA; Dimick JB; Sonnenday CJ
Arch Surg; 2010 Dec; 145(12):1158-63. PubMed ID: 21173289
[TBL] [Abstract][Full Text] [Related]
19. Five-year survival rates and time trends of laryngeal cancer in the US population.
Cosetti M; Yu GP; Schantz SP
Arch Otolaryngol Head Neck Surg; 2008 Apr; 134(4):370-9. PubMed ID: 18427002
[TBL] [Abstract][Full Text] [Related]
20. [Clinical characteristics and multivariate analysis of prognostic factors in recurrent laryngeal carcinoma].
Chen YF; Chen FJ; Yang AK; Zeng ZY; Song M; Li QL
Ai Zheng; 2004 May; 23(5):584-8. PubMed ID: 15142460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
